DESCRIPTION
A 64-year-old man with history of hypertension, coronary artery disease with coronary bypass was referred to our institution for further evaluation of disabling claudication. Previous history was significant for acute limb ischaemia mandating an emergent thromboembolectomy of his aortoiliac vessels. However, his symptoms persisted and he was subsequently referred to us for further management.
Ankle brachial index (ABI) was 0.51 on right lower extremity (RLE) and 0.48 on the left lower extremity (LLE). With exercise, the ABI worsened to 0.28 on the RLE and 0.43 on the LLE. Further workup with CT angiography revealed a totally occluded abdominal aorta in the infrarenal segment just distal to inferior mesenteric artery (IMA) and extending to common iliac arteries bilaterally (figure 1A). The external iliac arteries (EIA) were patent but severely diseased in their proximal segments. The common femoral arteries (CFA) were patent with moderate disease on the right and minimal disease on the left. After a well-informed discussion with the patient, we planned for an abdominal aortography and intervention on the occluded vascular segments.
Abdominal aortography, selective IMA angiography and selective bilateral angiography of the hypogastric arteries were performed. Notable angiographic findings were patent suprarenal aorta with patent bilateral renal arteries, occluded infrarenal aorta, critical IMA stenosis (99%) at the ostium, totally occluded bilateral common iliac arteries, and patent bilateral hypogastric arteries with retrograde flow filling the EIA bilaterally. Bilateral EIA, CFA, profunda femoris and superficial femoral arteries appeared patent. Percutaneous transluminal angioplasty with stent placement to the distal abdominal aorta and bilateral common iliac arteries were performed. Final angiography revealed a widely patent infrarenal abdominal aorta and bilateral common and external/internal iliac arteries resulting in restoration of grade 3 thrombosis in myocardial infarction (TIMI) blood flow (figure 1B). There was some residual narrowing observed within the distal abdominal prosthesis but was not intervened on, given the restoration of normal blood flow.
There were no immediate postprocedure complications. He was discharged after an uneventful 2-day hospital course. He was counselled regarding behavioural risk factor modification including diet, exercise and smoking cessation. He was discharged on aspirin 325 mg/day and clopidogrel 75 mg/day.
On his 4-week outpatient follow-up, he reported complete resolution of claudication symptoms in both legs. He could walk up to 3 miles without any discomfort as compared to only 10 feet distance prior to this procedure.
Total aortic occlusion is identified in 3-8.5% of patients presenting with aortoiliac disease.
1 It is considered class-D disease by TransAtlantic Inter-Society Consensus II (TASC II) classification. 2 Aortofemoral bypass is considered the treatment of choice with 5-year and 10-year patency rates up to 90% and 75%, respectively.
3-7 Extra anatomical bypass is also an option but associated with higher morbidity and shorter patency rates. 5 8 Despite excellent long-term outcomes, surgery has been associated with a higher perioperative mortality rate estimated from about 1% to 7% and a major early complication rate of 9-27%, including sexual dysfunction, ureteral damage, intestinal ischaemia and spinal cord injury. 5 9 10 Moreover, surgery is not a great treatment option for candidates who carry a high surgical risk of complications from open vascular surgery. Endovascular procedure remains an excellent alternative with short-to-midterm patency rates for focal stenosis approaching close to that of surgery.
Simons et al 9 reviewed seven major studies for treatment of mostly focal aortic stenosis and reported primary and secondary patency rates of 83-100% and 100%, respectively. Mean follow-up was 12-27 months. For complex or occlusive disease, a recent review of the long-term outcomes treated with endovascular therapy reported primary and secondary patency rates at 4-5 years ranging from 60% to 86% and 80% to 98%, respectively. 8 10 Besides plaque burden and complexity of the vascular disease, the mode of endovascular therapy may also affect outcomes. Initial experiences with angioplasty are now frequently supplemented with secondary stenting and/or thrombolytic therapy. Direct stenting may allow decreased risk for vessel rupture, procedural time and risk for thromboembolism. 11 Klonaris et al 4 reported primary patency rates of 83-100% on short-to-midterm follow-up (18-43 months). However in most prior studies, stenting has followed predilation. Future prospective studies are warranted to explore the long-term efficacy of direct stenting procedures. Also, the use of self-expanding versus balloondilated stents remains an issue for debate which needs to be studied in the future prospective investigations.
Nonetheless, the role of endovascular procedures in peripheral vascular disease appears emerging at tertiary care centres across the globe and certainly remains a promising therapeutic approach for patients with debilitating disease symptoms especially who carry a high-operative risk for open vascular surgery.
Learning points
▸ Endovascular stenting remains an excellent alternative for those at high risk for open surgery. ▸ The short-to-midterm patency rates for focal stenosis approach to those for surgery. ▸ Besides plaque burden and complexity of vascular disease, the mode of endovascular therapy may also affect outcomes. 
